CLONAL KARYOTYPE ABNORMALITIES AND CLINICAL-PROGRESS IN THE MYELODYSPLASTIC SYNDROME

被引:86
|
作者
GEDDES, AD
BOWEN, DT
JACOBS, A
机构
[1] Department of Haematology, University of Wales College of Medicine, Cardiff
关键词
D O I
10.1111/j.1365-2141.1990.tb07871.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Summary Summary Clonal karyotype abnormalities in 124 patients with myelodysplastic syndrome are reviewed. 36% of patients had abnormalities at referral, the most common being 5q ‐, +8 and lesions of chromosomes 7 and 20. Reduced survival was associated with the presence of either single or multiple clonal abnormalities at referral, abnormalities of chromosome 7 or 8 (either alone or with other lesions) and exclusively abnormal metaphases. The presence of 5q ‐alone did not appear to affect survival. Sequential studies were carried out in 77 patients of whom 12 showed karyotypic evolution. Reduced survival was observed in patients with an evolving karyotype but appeared to be due almost entirely to evolution in those patients whose initial karyotype was normal. Leukaemic transformation occurred more commonly in patients with an abnormal karyotype, particularly those with multiple abnormalities, and in patients with an evolving karyotype. Although the first appearance of an abnormal karyotype or an apparent evolution are important phenomena, it is probable that in some cases they merely represent expansion of a previously existing clone that has escaped detection. The distinction between true karyotypic evolution or clonal expansion and statistical variations due to small sample size and variability of samples may be difficult but needs to be taken into account in considering clinical significance. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:194 / 202
页数:9
相关论文
共 50 条
  • [31] CHRONIC CERVICAL DYSFUNCTION - CORRELATION OF MYOELECTRIC FINDINGS WITH CLINICAL-PROGRESS
    BEAL, MC
    VORRO, J
    JOHNSTON, WL
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1989, 89 (07): : 891 - 900
  • [32] Cytogenetic abnormalities in myelodysplastic syndrome: an overview
    Kawankar, Nikesh
    Vundinti, Babu Rao
    HEMATOLOGY, 2011, 16 (03) : 131 - 138
  • [33] Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
    Nagoshi, H.
    Horiike, S.
    Kuroda, J.
    Taniwaki, M.
    CURRENT MOLECULAR MEDICINE, 2011, 11 (08) : 678 - 685
  • [34] Chromosomal Abnormalities in Primary Myelodysplastic Syndrome
    Rashid, Anila
    Khurshid, Mohammad
    Shaikh, Usman
    Adil, Salman
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (09): : 632 - 635
  • [35] Hyperdiploid karyotype in a child with hypocellular primary myelodysplastic syndrome
    Fernandez, TD
    Ornellas, MH
    Tavares, RD
    Otero, L
    Diamond, HR
    Bouzas, LF
    Tabak, D
    Abdelhay, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (05) : 399 - 401
  • [37] Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
    Gondek, Lukasz P.
    DeZern, Amy E.
    LANCET HAEMATOLOGY, 2020, 7 (01): : E73 - E81
  • [38] Monosomal Karyotype Is Associated With Worse Survival Independent Of Complex Karyotype In Patients With Myelodysplastic Syndrome
    McQuilten, Zoe K.
    Sundararajan, Vijaya
    Wood, Erica M.
    Curtis, David J.
    Polizzotto, Mark N.
    Campbell, Lynda J.
    Wall, Meaghan
    BLOOD, 2013, 122 (21)
  • [39] Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia
    Duell, Thomas
    Poleck-Dehlin, Brigitte
    Schmid, Christoph
    Wunderlich, Bettina
    Ledderose, Georg
    Mittermueller, Johann
    Kolb, Hans Jochen
    Schmetzer, Helga
    ACTA HAEMATOLOGICA, 2006, 116 (02) : 131 - 136
  • [40] CLINICAL-PROGRESS AND QUADRICEPS TORQUE RATIOS DURING TRAINING OF MENISCECTOMY PATIENTS
    STAM, HJ
    BINKHORST, RA
    KUHLMANN, P
    VANNIEUWENHUYZEN, JE
    INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1992, 13 (02) : 183 - 188